A detailed history of Bell Investment Advisors, Inc transactions in Xencor Inc stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 19 shares of XNCR stock, worth $450. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19
Previous 19 -0.0%
Holding current value
$450
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$24.77 - $29.9 $421 - $508
-17 Reduced 47.22%
19 $0
Q1 2023

May 10, 2023

BUY
$25.95 - $36.95 $441 - $628
17 Added 89.47%
36 $1,000
Q3 2022

Nov 09, 2022

BUY
$24.62 - $32.44 $467 - $616
19 New
19 $0
Q2 2022

Aug 12, 2022

SELL
$19.74 - $29.01 $1,184 - $1,740
-60 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$33.67 - $43.44 $134 - $173
4 Added 7.14%
60 $2,000
Q3 2021

Nov 12, 2021

BUY
$30.65 - $35.68 $1,716 - $1,998
56 New
56 $2,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.42B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Bell Investment Advisors, Inc Portfolio

Follow Bell Investment Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bell Investment Advisors, Inc with notifications on news.